2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

[HTML][HTML] Smart wearables for cardiac monitoring—real-world use beyond atrial fibrillation

D Duncker, WY Ding, S Etheridge, PA Noseworthy… - Sensors, 2021 - mdpi.com
The possibilities and implementation of wearable cardiac monitoring beyond atrial fibrillation
are increasing continuously. This review focuses on the real-world use and evolution of …

2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients: Developed in …

MJ Shah, MJ Silka, JNA Silva, S Balaji… - Cardiology in the …, 2021 - cambridge.org
In view of the increasing complexity of both cardiovascular implantable electronic devices
(CIEDs) and patients in the current era, practice guidelines, by necessity, have become …

[HTML][HTML] 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients …

WC Members, MJ Shah, MJ Silka, JNA Silva… - JACC: Clinical …, 2021 - Elsevier
In view of the increasing complexity of both cardiovascular implantable electronic devices
(CIEDs) and patients in the current era, practice guidelines, by necessity, have become …

[HTML][HTML] Role of exercise as a modulating factor in arrhythmogenic cardiomyopathy

A Zorzi, A Cipriani, R Bariani, K Pilichou… - Current cardiology …, 2021 - Springer
Abstract Purpose of Review The review addresses the role of exercise in triggering
ventricular arrhythmias and promoting disease progression in arrhythmogenic …

Rationale and design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) study

N Moulson, BJ Petek, MJ Ackerman… - Journal of the …, 2023 - Am Heart Assoc
Background Clinical practice recommendations for participation in sports and exercise
among young competitive athletes with cardiovascular conditions at risk for sudden death …

Leisure-time and competitive sport participation: a changing paradigm for HCM patients

A Pelliccia, S Day, I Olivotto - European Journal of Preventive …, 2023 - academic.oup.com
HCM has long been considered the most frequent cause of death in athletes, and reason for
disqualification from sport. However, our perception of the impact of sports on HCM is largely …

[HTML][HTML] Sex-specific impacts of exercise on cardiovascular remodeling

RA Islam, SSS Khalsa, AK Vyas… - Journal of Clinical …, 2021 - mdpi.com
Cardiovascular diseases (CVD) remain the leading cause of death in men and women.
Biological sex plays a major role in cardiovascular physiology and pathological …

Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working …

JP Kaski, JAE Kammeraad, NA Blom… - Cardiology in the …, 2023 - cambridge.org
Sudden cardiac death is the most common mode of death during childhood and
adolescence in hypertrophic cardiomyopathy, and identifying those individuals at highest …

Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review

P Medeiros, M Santos, C Arantes, VH Pereira, S Rocha - Heart & Lung, 2023 - Elsevier
Background The potential benefit of implantable cardioverter-defibrillator (ICD) therapy in
individuals with inherited arrhythmia syndromes is well known. However, it is not deprived of …